908 Devices Inc. completed its acquisition of Nirlab Sa on 2026-05-04, according to the Form 8-K 908 Devices Inc. filed with the SEC on 2026-05-06. The filing states a price of $15 million.
| Acquirer | 908 Devices Inc. |
|---|---|
| Acquired | Nirlab Sa |
| Completed | 2026-05-04 |
| Price stated in the filing | $15 million |
| Reported by | 908 Devices Inc. (MASS), the buyer |
| Filing | Form 8-K, filed 2026-05-06 |
Want the whole picture on 908 Devices Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on 908 Devices Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on 908 Devices Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What the filing says
Share Purchase Agreement On May 4, 2026 (the "Closing Date"), 908 Devices Inc. (the "Company") completed its acquisition of NIRLAB SA, a corporation organized under the laws of Switzerland ("NIRLAB"), and its wholly owned subsidiary, NIRLAB Forensics S rl, a limited liability company organized under the laws of Switzerland (the "Subsidiary" and, together with NIRLAB, the "NIRLAB Group"), pursuant to a Share Purchase Agreement (the "Purchase Agreement") with Florentin Coppey, Pierre Esseiva, Matteo Delbr ck, Parkview Invest AG and Matthieu Girod (each a "Seller" and collectively, the "Sellers") and NIRLAB.
The price, in the filing's words
Pursuant to the Purchase Agreement, the Sellers agreed to sell and transfer to the Company, on the Closing Date (as defined below), all of the issued and outstanding NIRLAB Shares in exchange for a preliminary consideration (the "Preliminary Consideration") payable by the Company on the Closing Date with a headline price of $15,000,000 (the "Transaction"), comprised of (x) $13,000,000 in cash (the "Cash Consideration") and (y) 293,368 shares of common stock of the Company, par value $0.001 per share (each such share, a "Company Share") (the "Stock Consideration").
More from the filing
Entry into a Material Definitive Agreement.
The NIRLAB Group develops near-infrared (NIR) spectroscopy solutions for instant material identification.
Under the Purchase Agreement, the Sellers sold all 1,094,282 outstanding registered shares of NIRLAB (the "NIRLAB Shares"), constituting the entire issued share capital of NIRLAB, to the Company.
Quoted from 908 Devices Inc.'s Form 8-K.
This is the only completed acquisition 908 Devices Inc. reported under Item 2.01 in the last twelve months.
Who runs it now, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on 908 Devices Inc.Look up 908 Devices Inc. and see what is on record before you decide.
Get the free SnapshotWhere this comes from
A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.
Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.